Literature DB >> 25283757

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice.

Stefan Viktor Vormfelde1, Manar Abu Abed, Thanh Duc Hua, Simon Schneider, Tim Friede, Jean-François Chenot.   

Abstract

BACKGROUND: Orally anticoagulated patients with insufficient knowledge about their treatment have a higher risk of complications. Standardized patient education could raise their level of knowledge and improve time spent within target INR range.
METHODS: This cluster randomized trial included 319 anticoagulated patients drawn from 22 general medical practices. 185 patients received patient education, conducted by practice nurses, consisting of a video, a brochure, and a questionnaire; 134 control patients received only the brochure. The primary endpoint was knowledge about treatment six months after the patient education session. The secondary endpoints were time in the INR (international normalized ratio) target range and complications of anticoagulation.
RESULTS: Patients in the intervention and control groups were of comparable mean age (73 vs. 72 years). They answered a comparable number of questions correctly before the intervention (6.8 ± 0.2 vs. 6.7 ± 0.2) but differed significantly on this measure at six months (9.9 ± 0.2 vs. 7.6 ± 0.2, mean difference 2.3 questions, 95% confidence interval [CI] 1.5-3.1, p< 0.001). In the six months prior to the intervention, the INR was in the target range 65 ± 2% vs. 66 ± 3% of the time; in the six months afterward, 71 ± 1% vs. 64 ± 3% of the time (mean difference 7 percentage points, 95% CI -2 to -16 percentage points, p = 0.11). The complication rates were comparable in the two groups (12% vs. 16%, p = 0.30). Patients in the intervention group approved of patient education sessions to a greater extent than control patients (87% vs. 56%).
CONCLUSION: Patient education was found to be practical, to improve knowledge relating to patient safety in a durable manner, and to meet with the approval of the patients who received it. There was a statistically non-significant trend toward an improvement of the time spent in the INR target range. In view of the major knowledge deficits of orally anticoagulated patients, standardized patient education ought to be made a part of their routine care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25283757      PMCID: PMC4187020          DOI: 10.3238/arztebl.2014.0607

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  27 in total

1.  The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation.

Authors:  Waltraud Pfeilschifter; Sebastian Luger; Robert Brunkhorst; Edelgard Lindhoff-Last; Christian Foerch
Journal:  Cerebrovasc Dis       Date:  2013-09-11       Impact factor: 2.762

2.  A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.

Authors:  Talitha I Verhoef; Georgia Ragia; Anthonius de Boer; Rita Barallon; Genovefa Kolovou; Vana Kolovou; Stavros Konstantinides; Saskia Le Cessie; Efstratios Maltezos; Felix J M van der Meer; William K Redekop; Mary Remkes; Frits R Rosendaal; Rianne M F van Schie; Anna Tavridou; Dimitrios Tziakas; Mia Wadelius; Vangelis G Manolopoulos; Anke H Maitland-van der Zee
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

3.  Do pharmacogenetics have a role in the dosing of vitamin K antagonists?

Authors:  Bruce Furie
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

4.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

5.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

Review 6.  Assessing bleeding risk in patients taking anticoagulants.

Authors:  Marwa Shoeb; Margaret C Fang
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

7.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

Review 8.  Novel oral anticoagulants in cardiovascular disease.

Authors:  Pilar Gallego; Vanessa Roldán; Gregory Y H Lip
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-09-13       Impact factor: 2.457

9.  Multimedia educational interventions for consumers about prescribed and over-the-counter medications.

Authors:  Sabina Ciciriello; Renea V Johnston; Richard H Osborne; Ian Wicks; Tanya deKroo; Rosemary Clerehan; Clare O'Neill; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  A randomized trial of genotype-guided dosing of warfarin.

Authors:  Munir Pirmohamed; Girvan Burnside; Niclas Eriksson; Andrea L Jorgensen; Cheng Hock Toh; Toby Nicholson; Patrick Kesteven; Christina Christersson; Bengt Wahlström; Christina Stafberg; J Eunice Zhang; Julian B Leathart; Hugo Kohnke; Anke H Maitland-van der Zee; Paula R Williamson; Ann K Daly; Peter Avery; Farhad Kamali; Mia Wadelius
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

View more
  11 in total

1.  A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Authors:  Miney Paquette; Daniel M Witt; Anne Holbrook; Jane Skov; Jack Ansell; Holger J Schünemann; Wojtek Wiercioch; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-05-28

2.  Modern education, modern media: patient empowerment in today's medicine.

Authors:  Antonius Schneider
Journal:  Dtsch Arztebl Int       Date:  2014-09-12       Impact factor: 5.594

Review 3.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

4.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

5.  Disease understanding in patients newly diagnosed with atrial fibrillation.

Authors:  Brystana G Kaufman; Sunghee Kim; Karen Pieper; Larry A Allen; Bernard J Gersh; Gerald V Naccarelli; Michael D Ezekowitz; Gregg C Fonarow; Kenneth W Mahaffey; Daniel E Singer; Paul S Chan; James V Freeman; Jack Ansell; Peter R Kowey; James A Rieffel; Jonathan Piccini; Eric Peterson; Emily C O'Brien
Journal:  Heart       Date:  2017-08-08       Impact factor: 5.994

6.  Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial.

Authors:  Verena Maikranz; Andrea Siebenhofer; Lisa-R Ulrich; Karola Mergenthal; Sylvia Schulz-Rothe; Birgit Kemperdick; Sandra Rauck; Gudrun Pregartner; Andrea Berghold; Ferdinand M Gerlach; Juliana J Petersen
Journal:  BMC Fam Pract       Date:  2017-02-07       Impact factor: 2.497

7.  Quality of Stroke Patient Information Applied in Randomized Controlled Trials-Literature Review.

Authors:  Anna C Alegiani; Anne C Rahn; Anke Steckelberg; Götz Thomalla; Christoph Heesen; Sascha Köpke
Journal:  Front Neurol       Date:  2020-12-07       Impact factor: 4.003

8.  The Impact of a Pharmacist-led Warfarin Educational Video in a Saudi Setting.

Authors:  Sireen Abdul Rahim Shilbayeh
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

9.  Health literacy and knowledge in a cohort of Australian patients taking warfarin.

Authors:  Angela W Yiu; Beata V Bajorek
Journal:  Pharm Pract (Granada)       Date:  2018-03-24

10.  Development and validation of a questionnaire to self-assess patient knowledge of direct oral anticoagulants (KODOA-test).

Authors:  Corina Metaxas; Valerie Albert; Matthias Stahl; Kurt E Hersberger; Isabelle Arnet
Journal:  Drug Healthc Patient Saf       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.